A mechanistic study of the effects of LY518674 on HDL C [high-density lipoprotein cholesterol] metabolism.
Phase of Trial: Phase II
Latest Information Update: 14 Dec 2015
At a glance
- Drugs LY 518674 (Primary)
- Indications Low HDL cholesterol; Metabolic syndrome
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 22 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jan 2007 Status changed from recruiting